KRAS G12C inhibitor 26
KRAS G12C inhibitor 26 is a KRAS G12C inhibitor with antitumor effects (WO2021109737) [1].
Product Specifications
CAS Number
2648584-52-3
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-g12c-inhibitor-26.html
Solubility
10 mM in DMSO
Smiles
N#CC[C@@H]1N(C(C(F)=C)=O)CCN(C2=C(CO[C@H](C3=CC=CC=C3C(F)(F)F)C4)C4=NC(OC[C@H]5N(C)CCC5)=N2)C1
Molecular Formula
C29H32F4N6O3
Molecular Weight
588.60
References & Citations
[1]Zusheng Xu, et al. Oxygen-containing heterocyclic compound, preparation method and application thereof. WO2021109737A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
K-Ras
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040391-100 1x 100 µL
CD81 / TAPA-1 (1.3.3.22), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040965-500 1x 500 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040812-500 1x 500 µL
Tyrosinase (OCA1/812), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040874-100 1x 100 µL
PLAP (Placental Alkaline Phosphatase) (GM022), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details